Featured Research

from universities, journals, and other organizations

'Super Glue' Seals Bypass Grafts

Date:
April 14, 2004
Source:
Baylor College Of Medicine
Summary:
Surgeons at Baylor College of Medicine in Houston are studying whether a liquid sealant, similar to common household "super glue," forms a tight seal around blood vessels used in vascular graft surgery.

HOUSTON -- Got a broken teacup, an art project, or a leaky blood vessel? “Super glue” it.

Related Articles


Surgeons at Baylor College of Medicine in Houston are studying whether a liquid sealant, similar to common household “super glue,” forms a tight seal around blood vessels used in vascular graft surgery.

“When you sew blood vessels together for a graft, they sometimes leak,” said Dr. Alan Lumsden, chief of the vascular surgery section of the Michael E. DeBakey Department of Surgery and principal investigator for the clinical trial. “In this trial, we will seal that leak, or basically “super glue” it together.”

Doctors currently use the glue to close skin wounds instead of using sutures, and are now studying it for vascular grafts. The sealant, manufactured by Closure Medical Corporation, is designed to provide a strong physical seal that remains in place longer than the graft takes to heal naturally. Over time, the seal will break down into smaller absorbable fragments.

Lumsden is the principal investigator of the international clinical trial, which will enroll up to 150 patients at 14 institutions in the United States and Europe. Surgeries will be performed at The Methodist Hospital and the Michael E. DeBakey Houston VA Medical Center. Candidates for the study are patients who are having femoral-popliteal bypass or AV access shunt surgery, two procedures that improve blood flow. Ideal candidates for the surgery are those who will be receiving artificial grafts, which bleed more, leading to surgical complications.

Other methods currently available to seal leaky blood vessels use biological agents to clot the blood. Since the vascular sealant is synthetic, it carries no risk of viral contamination or rejection that may occur with biological agents.

“The idea is that we can use this glue to join two blood vessels which allows blood to flow from one to the other--something we currently cannot do,” Lumsden said.

Patients in the trial will either receive the procedure using the glue, or sutures alone. Researchers will then compare the procedures to measure blood loss and the time the procedure takes to complete.

“Because we cannot create a tight, leak-proof seal between blood vessels, vascular surgeons are unable to perform laparascopic vascular surgery, a minimally invasive form of surgery,” Lumsden said. “The glue opens up all types of possibilities in terms of vascular graft surgery.”


Story Source:

The above story is based on materials provided by Baylor College Of Medicine. Note: Materials may be edited for content and length.


Cite This Page:

Baylor College Of Medicine. "'Super Glue' Seals Bypass Grafts." ScienceDaily. ScienceDaily, 14 April 2004. <www.sciencedaily.com/releases/2004/04/040414003300.htm>.
Baylor College Of Medicine. (2004, April 14). 'Super Glue' Seals Bypass Grafts. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2004/04/040414003300.htm
Baylor College Of Medicine. "'Super Glue' Seals Bypass Grafts." ScienceDaily. www.sciencedaily.com/releases/2004/04/040414003300.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins